-
effectivehealthcare-admin.ahrq.gov/products/migraine-emergency/research
December 01, 2019 - No two studies reported the same side effects for the same pair of interventions; therefore, the SOE … Few side effects were reported for NSAIDS or opioids. … In patients receiving magnesium sulfate, high rates of skin flushing and local reactions were reported
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse/research
December 01, 2019 - weighted mean difference [WMD], 3.6, 95% confidence interval [CI], 2.4 to 4.8), 12 percent fewer subjects reported … heavy drinking episodes (risk difference 0.12, 95% CI, 0.07 to 0.16), and 11 percent more subjects reported … randomized subjects, practices, or providers to screening and a comparator, and none of the included studies reported
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - We reported the results
for adults and children separately:
“We reported the results of our
systematic … We reported the results
for adults and children separately:
“We reported the results of our
systematic … No marked elevations in
AST were reported. … These are reported in Table 26. … Results are reported efficacy from clinical trials.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/tech-brief-32-pharm-non-pharm-ptsd.pdf
May 14, 2019 - the paper reported the statistics for this comparison. … However, calculating effect sizes and
other types of data not originally reported
within a study can … Skill was not
abstracted because it is infrequently reported
in studies. … These other comorbidities are reported as part
of population characteristics when studies
reported … If multiple disorders will be reported,
separate data elements should be created.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
June 01, 2017 - In general, the results not reported were
10
quality of life outcomes (See bolded text in Table … Table 6
shows the baselines that were reported in both the record and the paper. … The record gave far less
baseline information than the paper, but what was reported matched exactly. … Results that were
reported in both the record and the paper are in Table 7. … Again, the paper gave much more detail
and included statistical analyses not reported in the record,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - One study reported a median survival
of 11.8 months.65 The other study reported a 1-year survival of … 20%.74
RFA Insufficient Only one study reported data on overall survival. … SBRT Insufficient One study reported no major complications.69 Other adverse events are reported in … HAI Insufficient One study reported no major complications.81 One study reported 1.8% increased
bilirubin … .90
RE Insufficient Two studies reported no major complications.82,84 Liver failure was reported in
-
effectivehealthcare-admin.ahrq.gov/products/transparency-omega-3/research-protocol
January 01, 2019 - Results data for only the longest-reported followup time in the registry record will be extracted. … For outcome instantiations that are reported in both, we will record whether the quantitative results … were all components of composite outcomes reported? … There is UNCLEAR RISK OF BIAS if these data were not reported. … UNCLEAR RISK OF BIAS if not or poorly reported.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
December 01, 2021 - In the other studies that
reported results from multivariate models, correlations between infection … One trial reported no difference in the subgroup of laboratory-confirmed (not necessarily
symptomatic … When reported, the most common adverse
events were discomfort, breathing difficulties, and skin events … We calculated risk estimates if they were not reported and data were available. … Yes Yes Yes Fair
MacIntyre C,
201330 Unclear Unclear No No Unclear Yes None reported Yes Yes Yes
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - ARB); events reported, it was difficult to discern any differential
Insufficient effect of ACEIs versus … In 21 studies
ARB) that reported mortality, MI, or clinical stroke as outcomes
among 38,589 subjects … , 38 deaths and 13 strokes were
reported. … There was no evidence of differences across treatments in
rates of other commonly reported specific … Furthermore, others have
reported a three- to fourfold increased risk of
angioedema in African-American
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
July 26, 2012 - Of 8 trials that reported prevalence of
hyperoxaluria, 3 defined it. … Of 7 trials that reported prevalence of
hypocitraturia, 4 defined it. … and
reported it as an important clinical outcome. … it in all studies that
reported recurrent stones. … Most trials
reported some baseline biochemical data.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
September 01, 2014 - In the
current report, five RCTs (reported in four articles)
reported on the effect of vitamin D supplementation … The
RCTs reported inconsistent results. … Three studies reported
on only one specific outcome, hypercalcemia/serum
calcium, or reported on this … Eleven RCTs reported
at least one adverse event. … Findings on
clinical outcomes are reported above.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - A total of five deaths were reported across
two studies. … to iron therapy (if reported). … Insufficient • Only 7 of the 27 studies reported information:
– 3 studies reported no adverse … – A total of 5 deaths reported. … – Most of the reported harms were attributed to iron therapy.
Key Question 3.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-disposition-comments.pdf
August 29, 2023 - Upon review of our data in the
meta-analysis, 2 studies reported
data for less than 4 weeks:
Foro … Although this
information was not included in
results tables, where OS is
reported, it is described … that my impact prognosis
and the extent to which studies
reported information on prognosis. … Where OS
is reported, it is described in the
appendices for secondary
outcomes. … that my impact prognosis
and the extent to which studies
reported these.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - in a variety of ways.12 Growth indices such as height and
weight are reported as either absolute values … The most commonly
reported of these will be selected for meta-analysis, while the remaining outcomes … will be
reported qualitatively. … Growth indices are also reported in many ways, including absolute values of height, height
percentile … When
given multiple height and weight outcomes, the most commonly reported outcomes will be
selected
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - Factors that may potentially limit
applicability were reported in the results. … Eleven bipolar studies reported symptom improvement. … Adverse events were reported in 36 studies comparing
SGAs with placebo. … Other outcomes were reported by four studies on
Tourette syndrome and two studies on behavioral
issues … Numerous studies reported separate outcomes for
various subpopulations; however, few consistent trends
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
April 01, 2013 - 2011 is incorrectly
reported as “621/805.” … The correct
number of reported biopsies is “105” as shown in Table 1. … The correct
number of reported biopsies is “187” as shown in Table 1. … PCA3 “1-Spec” is reported as “35.1” and “Sens” as “77.1.” … This finding has been reported in another article
(Thompson et al.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - None of the abstracts reported adverse
events. … No change in survival
outcome was reported. … In the remainder of the primary
studies, two reported on lesion characterization and three reported … No clinical outcomes were reported. … No adverse events
reported.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - level (0 to 10, 10 high): 5.7
Level of functioning (VAS, 0 to 100) 58
Urine + for opiates: 63%
Self-reported … 89% Screened: 65
Eligible: 25
Randomized: 19
Analyzed: 19
LTFU: 9 Outcomes at 6 month follow-up not reported … indicate clear differences between treatments for pain, functioning, depression, or drug use Harms not reported … in 2 consecutive rounds before the last round of followup
B) Intermittent opioid use: opioid use reported … in any one of the rounds
C) No use: no opioid use reported in any rounds Enrolled: 4,172
Analyzed: 4,172
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - Minor adverse effects such as cold extremities, diarrhea, rash, and sleep
changes were also reported … with the
pulse dye laser, with hypopigmentation being reported more frequently.
���
Bleeding 1 121 … ��Case series have reported associations between multiple
cutaneous IH lesions and increased risk for … ��A proportion of children with IH were reported to have
limited or no response to beta-blockers. … The type of IH
was not consistently reported.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - For leflunomide vs. sulfasalazine, data are limited to
one RCT with 2-year followup that reported that … No differences in tolerability were reported for
leflunomide, methotrexate, and sulfasalazine in three … One study in
patients with early RA, however, reported improved
DAS scores at 18 months with combination … It reported less radiographic
progression over 12 months with either (1) metho-
trexate, sulfasalazine … A prospective, population-based cohort study from
Sweden, enrolling more than 1,100 patients, reported